ArticleThe breast journal2025

Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple-Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden.

Atif Ali Hashmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.